Clinical Trial Update: Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of aprepitant injection for preventing postoperative nausea and vomiting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Aprepitant Injection (aprepitant)

Snippet

Sponsor: Qilu Pharmaceutical (Hainan) Co., Ltd. | Conditions: Postoperative Nausea and Vomiting | Phase 3 | Status: COMPLETED